NKG2D ligands in tumor immunity

Area of Science:

• Immunology
• Cancer Biology
• Molecular Biology

Background:

• The activating receptor NKG2D (natural-killer group 2, member D) is vital for immune responses against tumors.
• NKG2D ligands are expressed on tumor cells but not healthy tissues, requiring tight regulation.
• Tumor immune escape can be mediated by modulating NKG2D ligand expression.

Purpose of the Study:

• To review current knowledge on the NKG2D receptor and its ligands in tumor immunology.
• To discuss strategies for enhancing NKG2D-mediated anti-tumor responses.
• To explore mechanisms counteracting tumor immune escape via NKG2D.

Main Methods:

• Literature review of studies on NKG2D, its ligands, and tumor immunology.
• Analysis of regulatory mechanisms controlling NKG2D expression and signaling.
• Synthesis of information on therapeutic strategies targeting NKG2D pathways.

Main Results:

• NKG2D plays a key role in NK, gammadelta T, and CD8 T cell responses to tumors.
• NKG2D signaling is coupled to the IL-15 receptor pathway in a cell-specific manner.
• Regulation of NKG2D ligands is critical for balancing anti-tumor immunity and self-tissue protection.

Conclusions:

• NKG2D-mediated immunity is a significant factor in tumor surveillance.
• Understanding the interplay between NKG2D, IL-15, and the tumor microenvironment is crucial for effective cancer immunotherapy.
• Targeting NKG2D pathways offers potential for novel anti-cancer strategies.